2020
DOI: 10.1186/s13662-020-02893-6
|View full text |Cite
|
Sign up to set email alerts
|

Modeling dynamics of cancer virotherapy with immune response

Abstract: Virotherapy is a therapeutic treatment for cancer. It uses genetically engineered viruses to selectively infect, replicate in, and destroy cancer cells without damaging normal cells. In this paper, we present a modified model to include, within the dynamics of virotherapy, the interaction between uninfected tumor cells and immune response. The model is analyzed qualitatively to produce five equilibrium points. One of these equilibriums demonstrates the effect observed in virotherapy, where the immune system de… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
3
1

Relationship

1
7

Authors

Journals

citations
Cited by 18 publications
(13 citation statements)
references
References 24 publications
1
11
0
Order By: Relevance
“…Various mathematical models to characterize in vitro viral dynamics (Bagheri et al, 2011;Titze et al, 2017), in vivo behavior limited to tumor size metrics (Bajzer et al, 2008;Eftimie et al, 2011), theoretical frameworks (Wein et al, 2003;Mok et al, 2009;Paiva et al, 2009;Malinzi et al, 2017;Jenner et al, 2018;Cassidy and Humphries, 2019;Al-Tuwairqi et al, 2020) and develop predictive in-silico trials (Jenner et al, 2021) have been so far described. To the best of our knowledge, the integration of kinetic parameters including viral distribution to tumor lesions and comparing i. t. and i. v. administrations has not yet been addressed.…”
Section: Introductionmentioning
confidence: 99%
“…Various mathematical models to characterize in vitro viral dynamics (Bagheri et al, 2011;Titze et al, 2017), in vivo behavior limited to tumor size metrics (Bajzer et al, 2008;Eftimie et al, 2011), theoretical frameworks (Wein et al, 2003;Mok et al, 2009;Paiva et al, 2009;Malinzi et al, 2017;Jenner et al, 2018;Cassidy and Humphries, 2019;Al-Tuwairqi et al, 2020) and develop predictive in-silico trials (Jenner et al, 2021) have been so far described. To the best of our knowledge, the integration of kinetic parameters including viral distribution to tumor lesions and comparing i. t. and i. v. administrations has not yet been addressed.…”
Section: Introductionmentioning
confidence: 99%
“…It is easy to see that the conditions of the Picard-Lindelöf theorem are fulfilled, since every function of the right-hand side of system (2) is continuous, just like its partial derivative with respect to every variable. Thus, we have that there exists a unique solution to problem (2)- (3). In fact, we can extended the solution and consider it in the maximal non-negative interval of existence.…”
Section: Preliminary Resultsmentioning
confidence: 97%
“…T yields θ B m T > 1 b , whereas choosing the value m B T yields θ B m T < 1 b , allowing us to explore the different dynamics of problem ( 2)- (3).…”
Section: Thus Choosing the Value M Amentioning
confidence: 99%
See 1 more Smart Citation
“…Most previous studies have examined the obesity models numerically due to their complexity. However, qualitative analysis of mathematical models [9,12,18,28] presents more general results and allows for better understanding of the critical parameters that play a significant role in the dynamics of the models, see for example [1][2][3]19].…”
Section: Introductionmentioning
confidence: 99%